TY - JOUR AU - D'Antonio, C. AU - Passaro, A. AU - Gori, B. PY - 2014 DA - 2014// TI - Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies JO - Adv Med Oncol VL - 6 UR - https://doi.org/10.1177/1758834014521110 DO - 10.1177/1758834014521110 ID - D'Antonio2014 ER - TY - JOUR AU - Iuchi, T. AU - Shingyoji, M. AU - Itakura, M. PY - 2014 DA - 2014// TI - Frequency of brain metastases in non-small cell lung cancer, and their association with epidermal growth factor receptor mutations JO - Int J Clin Oncol VL - 20 UR - https://doi.org/10.1007/s10147-014-0760-9 DO - 10.1007/s10147-014-0760-9 ID - Iuchi2014 ER - TY - JOUR AU - Mitsudomi, T. AU - Morita, S. AU - Yatabe, Y. PY - 2010 DA - 2010// TI - Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(09)70364-X DO - 10.1016/S1470-2045(09)70364-X ID - Mitsudomi2010 ER - TY - JOUR AU - Maemondo, M. AU - Inoue, A. AU - Kobayashi, K. PY - 2010 DA - 2010// TI - Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909530 DO - 10.1056/NEJMoa0909530 ID - Maemondo2010 ER - TY - JOUR AU - Zhou, C. AU - Wu, Y. L. AU - Chen, G. PY - 2011 DA - 2011// TI - Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study JO - Lancet Oncol. VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70184-X DO - 10.1016/S1470-2045(11)70184-X ID - Zhou2011 ER - TY - JOUR AU - Rosell, R. AU - Carcereny, E. AU - Gervais, R. PY - 2012 DA - 2012// TI - Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial JO - Lancet Oncol. VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70393-X DO - 10.1016/S1470-2045(11)70393-X ID - Rosell2012 ER - TY - JOUR AU - Namba, Y. AU - Kijima, T. AU - Yokota, S. PY - 2004 DA - 2004// TI - Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases JO - Clin Lung Cancer VL - 6 UR - https://doi.org/10.3816/CLC.2004.n.026 DO - 10.3816/CLC.2004.n.026 ID - Namba2004 ER - TY - JOUR AU - Ceresoli, G. L. AU - Cappuzzo, F. AU - Gregorc, V. PY - 2004 DA - 2004// TI - Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh276 DO - 10.1093/annonc/mdh276 ID - Ceresoli2004 ER - TY - JOUR AU - Bai, H. AU - Han, B. PY - 2013 DA - 2013// TI - The effectiveness of erlotinib against brain metastases in non-small cell lung cancer patients JO - Am J Clin Oncol VL - 36 UR - https://doi.org/10.1097/COC.0b013e3182438c91 DO - 10.1097/COC.0b013e3182438c91 ID - Bai2013 ER - TY - JOUR AU - Iuchi, T. AU - Shingyoji, M. AU - Sakaida, T. PY - 2013 DA - 2013// TI - Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma JO - Lung Cancer VL - 82 UR - https://doi.org/10.1016/j.lungcan.2013.08.016 DO - 10.1016/j.lungcan.2013.08.016 ID - Iuchi2013 ER - TY - JOUR AU - Omuro, A. M. AU - Kris, M. G. AU - Miller, V. A. PY - 2005 DA - 2005// TI - High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.21033 DO - 10.1002/cncr.21033 ID - Omuro2005 ER - TY - JOUR AU - Yamamoto, N. AU - Goto, K. AU - Nishio, M. PY - 2017 DA - 2017// TI - Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer JO - Int J Clin Oncol VL - 22 UR - https://doi.org/10.1007/s10147-016-1039-0 DO - 10.1007/s10147-016-1039-0 ID - Yamamoto2017 ER - TY - JOUR AU - Urata, Y. AU - Katakami, N. AU - Morita, S. PY - 2016 DA - 2016// TI - Randomized phase III study comparing gefitinib with erlotinib in patients with previously treated advanced lung adenocarcinoma: WJOG 5108L JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.4154 DO - 10.1200/JCO.2015.63.4154 ID - Urata2016 ER - TY - JOUR AU - Hidalgo, M. AU - Siu, L. L. AU - Nemunaitis, J. PY - 2001 DA - 2001// TI - Phase I and pharmacologic study of OSI−774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.13.3267 DO - 10.1200/JCO.2001.19.13.3267 ID - Hidalgo2001 ER - TY - JOUR AU - Ranson, M. AU - Hammond, L. A. AU - Ferry, D. PY - 2002 DA - 2002// TI - ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.10.112 DO - 10.1200/JCO.2002.10.112 ID - Ranson2002 ER - TY - JOUR AU - Togashi, Y. AU - Masago, K. AU - Masuda, S. PY - 2012 DA - 2012// TI - Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer JO - Cancer Chemother Pharmaco VL - 70 UR - https://doi.org/10.1007/s00280-012-1929-4 DO - 10.1007/s00280-012-1929-4 ID - Togashi2012 ER - TY - JOUR AU - Jamal-Hanjani, M. AU - Spicer, J. PY - 2012 DA - 2012// TI - Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2529 DO - 10.1158/1078-0432.CCR-11-2529 ID - Jamal-Hanjani2012 ER - TY - JOUR AU - Zeng, Y. D. AU - Liao, H. AU - Qin, T. PY - 2015 DA - 2015// TI - Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3187 DO - 10.18632/oncotarget.3187 ID - Zeng2015 ER - TY - JOUR AU - Magnuson, W. i. l. l. i. a. m. J. AU - Lester-Coll, N. a. t. a. n. i. e. l. H. AU - Wu, A. b. r. a. h. a. m. J. AU - Yang, T. J. o. n. a. t. h. a. n. AU - Lockney, N. a. t. a. l. i. e. A. AU - Gerber, N. a. a. m. i. t. K. AU - Beal, K. a. t. h. r. y. n. AU - Amini, A. r. y. a. AU - Patil, T. e. j. a. s. AU - Kavanagh, B. r. i. a. n. D. AU - Camidge, D. R. o. s. s. AU - Braunstein, S. t. e. v. e. n. E. AU - Boreta, L. a. u. r. e. n. C. AU - Balasubramanian, S. u. r. e. s. h. K. AU - Ahluwalia, M. a. n. m. e. e. t. S. AU - Rana, N. i. t. e. s. h. k. u. m. a. r. G. AU - Attia, A. l. b. e. r. t. AU - Gettinger, S. c. o. t. t. N. AU - Contessa, J. o. s. e. p. h. N. AU - Yu, J. a. m. e. s. B. AU - Chiang, V. e. r. o. n. i. c. a. L. PY - 2017 DA - 2017// TI - Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis JO - Journal of Clinical Oncology VL - 35 UR - https://doi.org/10.1200/JCO.2016.69.7144 DO - 10.1200/JCO.2016.69.7144 ID - Magnuson2017 ER - TY - JOUR AU - Lee, C. K. AU - Wu, Y. L. AU - Ding, P. N. PY - 2015 DA - 2015// TI - Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung Cancer: a meta-analysis JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.1736 DO - 10.1200/JCO.2014.58.1736 ID - Lee2015 ER - TY - JOUR AU - Kudoh, S. AU - Kato, H. AU - Nishikawa, Y. PY - 2008 DA - 2008// TI - Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study JO - Am J Respir Crit Care Med VL - 177 UR - https://doi.org/10.1164/rccm.200710-1501OC DO - 10.1164/rccm.200710-1501OC ID - Kudoh2008 ER - TY - JOUR AU - Walbert, T. AU - Gilbert, M. R. PY - 2009 DA - 2009// TI - The role of chemotherapy in the treatment of patients with brain metastases from solid tumors JO - Int J Clin Oncol VL - 14 UR - https://doi.org/10.1007/s10147-009-0916-1 DO - 10.1007/s10147-009-0916-1 ID - Walbert2009 ER - TY - JOUR AU - Aiko, N. AU - Shimokawa, T. AU - Miyazaki, K. PY - 2017 DA - 2017// TI - Comparison of the efficacy of first-generation EGFR-TKIs in brain metastasis JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2016.11.1300 DO - 10.1016/j.jtho.2016.11.1300 ID - Aiko2017 ER -